Lambda Light Chain Antibody (1-155-2) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-79124F
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
CyTOF-ready, Flow Cytometry
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # 1-155-2
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Lambda Light Chain Antibody (1-155-2) [FITC]
Immunogen
Human IgA1 lambda myeloma protein
Specificity
The mouse monoclonal antibody 1-155-2 recognizes lambda light chains (22.5 kDa) of human immunoglobulin.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for Lambda Light Chain Antibody (1-155-2) [FITC]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Lambda Light Chain
Alternate Names
IGLC, immunoglobulin lambda constant group
Gene Symbol
IGLC1
Additional Lambda Light Chain Products
Product Documents for Lambda Light Chain Antibody (1-155-2) [FITC]
Product Specific Notices for Lambda Light Chain Antibody (1-155-2) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...